Avoro Capital Advisors LLC Kymera Therapeutics, Inc. Transaction History

Avoro Capital Advisors LLC

$7.33 Billion
Q2 2024

A detailed history of Avoro Capital Advisors LLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 3,888,888 shares of KYMR stock, worth $189 Million. This represents 1.58% of its overall portfolio holdings.

Number of Shares

3,888,888

Previous 3,888,888 -0.0%

Holding current value

$189 Million

Previous $156 Million 25.75%

% of portfolio

1.58%

Previous 1.88%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$22.9 - $43.57 $2.61 Million - $4.96 Million	113,888 Added 3.02%	3,888,888 $156 Million
Q4 2023 Feb 14, 2024	SELL	$10.97 - $26.84 $877,600 - $2.15 Million	-80,000 Reduced 2.08%	3,775,000 $96.1 Million
Q1 2023 May 15, 2023	BUY	$24.84 - $38.75 $124,200 - $193,750	5,000 Added 0.13%	3,855,000 $114 Million
Q4 2022 Feb 14, 2023	BUY	$19.57 - $30.92 $32.9 Million - $52 Million	1,680,770 Added 77.48%	3,850,000 $96.1 Million
Q3 2022 Nov 14, 2022	BUY	$20.91 - $34.27 $19 Million - $31.2 Million	909,230 Added 72.16%	2,169,230 $47.2 Million
Q2 2022 Aug 15, 2022	BUY	$14.13 - $42.55 $6.27 Million - $18.9 Million	443,500 Added 54.32%	1,260,000 $24.8 Million
Q1 2022 May 16, 2022	BUY	$35.3 - $64.68 $9.41 Million - $17.2 Million	266,500 Added 48.45%	816,500 $34.6 Million
Q4 2021 Feb 14, 2022	BUY	$49.91 - $65.56 $4.7 Million - $6.18 Million	94,250 Added 20.68%	550,000 $34.9 Million
Q3 2021 Nov 15, 2021	BUY	$47.8 - $66.66 $21.8 Million - $30.4 Million	455,750 New	455,750 $26.8 Million
Q4 2020 Feb 16, 2021	SELL	$28.07 - $87.83 $1.39 Million - $4.34 Million	-49,400 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$26.1 - $33.28 $1.29 Million - $1.64 Million	49,400 New	49,400 $1.6 Million

Others Institutions Holding KYMR

# of Institutions

160

Shares Held

63.1M

Call Options Held

22.6K

Put Options Held

14.4K

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.66B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avoro Capital Advisors LLC with notifications on news.

Account

Avoro Capital Advisors LLC Kymera Therapeutics, Inc. Transaction History